Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.
申请公布号
WO2013112949(A3)
申请公布日期
2013.09.19
申请号
WO2013US23312
申请日期
2013.01.25
申请人
VANDA PHARMACEUTICALS INC.
发明人
DRESSMAN, MARLENE, MICHELLE;FEENEY, JOHN, JOSEPH;LICAMELE, LOUIS, WILLIAM;POLYMEROPOULOS, MIHAEL, H.